Cronos Group Inc.

$2.75 USD

$0.01 (0.36%)

Volume: 651.62K
Average Volume: 1.54M
Market Capitalization: $1.03B
P/E Ratio: -1256.91
Dividend Yield: 0.00%
Price Target: $2.90

Year High: $3.43
Year Low: $1.93
Day High: —
Day Low: —
Payout Ratio: $0.00
Current Ratio: $21.87

Industry, Sector & symbol

Stock Exchange	NASDAQ
CEO	Michael Ryan Gorenstein
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Current Symbol	CRON
CUSIP	22717L101
CIK	0001656472
Web	https://www.thecronosgroup.com
Phone	14165040004
Currency	USD
Employees	610
Country	CA

Liquidity

Debt-to-Equity Ratio	0.00
Payout Ratio	0.00
Current Ratio	21.87
Quick Ratio	20.73
Cash Ratio	19.37

Sales & Book Value

Annual Sales	$149.15M
Price / Sales	6.48
Cash Flow	0.07
Price / Cash Flow	39.07
Price / Book	0.98

Price Target and Rating

Average Stock Price Forecast	$2.90
High Stock Price Forecast	$4.50
Low Stock Price Forecast	$2.30
Forecast Upside/Downside	-5.17%
Consensus Rating	Neutral
Rating Score(0-5)	3
Research Coverage	15 Analysts

Profitability

EPS (Most Recent Fiscal Year)	-$0.0251
Trailing P/E Ratio	-1256.91
PEG Ratio	10.00
P/E Growth	10.00
Net Income	-$9.61M
Net Margin	-1.29%
Pretax Margin	-4.22%
Return on Equity	-0.19%
Return on Assets	-0.18%

Financials Score

AltmanZ Score	14.27
Piotroski Score	3.00
Working Capital	888.37M
Total Assets	1.18B
Ebit	-15.04M
Market Cap	1.02B
Total Liabilities	48.45M

Poll Results

About Cronos Group Inc. (NASDAQ:CRON) Stock

Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption. Its cannabis offerings encompass dried flower, pre-rolled joints, edibles, concentrates, and various extracts, which are distributed via wholesale channels and directly to clients. The wellness segment operates under the PEACE NATURALS platform, while its adult-use products are marketed thro ... ugh the Spinach brand. Additionally, Cronos exports dried cannabis and cannabis oils to international markets such as Germany, Israel, and Australia. Founded in 2012, the company's headquarters are located in Toronto, Canada.

Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026

2026-07-16 07:30:00

TORONTO, July 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 second quarter earnings conference call on Thursday, August 6, 2026 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

3 Canadian Marijuana Stocks For Better Investing And Trading 2026

2026-07-15 11:21:32

For investors looking to make more green, marijuana stocks may be the way to go. Contrary to the doubt or fear based on the past, the cannabis industry is growing at a fast pace. Now, with cannabis classified as a Class 3 substance, there is very little barrier for legal operators. What that means is now there can be more product research and testing.

Top Canadian Marijuana Stock Picks For Investors Today

2026-07-06 12:42:01

As the cannabis sector continues to grow, it has marijuana stock investors seeing green. There has been a long, volatile battle for most of the time cannabis companies have been publicly traded. Even during the moments when many used pot stocks to get quick profits, given how the sector once began. At one point, a great deal of hype and speculation fueled investors in taking up positions for particular cannabis stocks.

Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada

2026-06-30 17:15:00

TORONTO, June 30, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) (TSX: CRON), an innovative global cannabis company, announced today that it has appointed ATB Capital Markets Corp. (“ATB Cormark”) to act as its broker in connection with share repurchases over the facilities of the TSX or other alternative Canadian trading systems, in place of Virtu Canada Corp., under its previously announced share repurchase program.

CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying?

2026-06-24 09:25:32

Cronos Group posts 40% Q1 revenue growth, gains share in Canada and expands abroad, but fierce cannabis competition keeps investors cautious.

Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders

2026-06-22 17:30:00

TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") today announced that at its Annual Meeting of Shareholders held on Thursday, June 18, 2026 (the "Meeting"), shareholders holding a total of 271,828,759 common shares of the Company voted in person or by proxy, representing 72.

Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders

2026-06-22 17:30:00

TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Thursday, June 18, 2026 (the “Meeting”), shareholders holding a total of 271,828,759 common shares of the Company voted in person or by proxy, representing 72.24% of the total number of common shares of the Company outstanding.

3 Marijuana Stocks Investors Can See Returns On Before The End Of The Year

2026-06-17 13:26:45

A lot is going on in the cannabis industry between the USA and Canadian markets. As more people and companies prepare for the road ahead with the rescheduling of cannabis. This has put a lot of pressure on legal operators to make the necessary adjustments to remain compliant. However, this also impacts marijuana stock investors both in the short and long term.

Frequently Asked Questions

What is the current Cronos Group Inc. (CRON) stock price?: Cronos Group Inc.(NASDAQ:CRON) stock price is $2.75 in the last trading session. During the trading session, CRON stock reached the peak price of $3.43 while $1.925 was the lowest point it dropped to. The percentage change in CRON stock occurred in the recent session was 0.36% while the dollar amount for the price change in CRON stock was $0.01.
CRON's industry and sector of operation?: The NASDAQ listed CRON is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
Who are the executives of CRON?: Adam Wagner | General Manager of Cronos Israel
Harrison Aaron | Senior Director of Investor Relations & Corporate Development
Anna Shlimak | Chief Financial Officer
Shannon Buggy | Senior Vice President & Global Head of People
Jeffrey David Jacobson | Chief Growth Officer
How many employees does CRON have?: Number of CRON employees currently stands at 610. CRON operates from 111 Peter Street, Stayner, ON M5V 2H1, CA.

Link for CRON official website?: Official Website of CRON is: https://www.thecronosgroup.com
How do I contact CRON?: CRON could be contacted at phone #14165040004 and can also be accessed through its website. CRON operates from 111 Peter Street, Stayner, ON M5V 2H1, CA.
How many shares of CRON are traded daily?: The average number of CRON shares traded daily for last 3 months was 1.54M.
What is the market cap of CRON currently?: The market value of CRON currently stands at $1.03B with its latest stock price at $2.75